Multiple Choice

A pharmaceutical company spends billions on R&D to create a breakthrough vaccine for a non-contagious disease. The marginal cost to produce each dose is only $1. To recoup its initial investment and make a profit, the company prices the vaccine at $500 per dose. This price means that many people who would benefit from the vaccine and are willing to pay more than the $1 marginal cost cannot afford it. Which statement provides the most accurate economic evaluation of this situation from a social welfare perspective?

0

1

Updated 2025-07-30

Contributors are:

Who are from:

Tags

Social Science

Empirical Science

Science

Economy

CORE Econ

Economics

Introduction to Microeconomics Course

The Economy 2.0 Microeconomics @ CORE Econ

Related